Gynecologic Oncology Tumor Board 2025A-26 - 6/18/2025

Add to Calendar Gynecologic Oncology Tumor Board 2025A-26 - 6/18/2025 6/18/2025 7:00:00 AM 6/18/2025 8:00:00 AM America/Chicago For More Details: https://vumc.cloud-cme.com/course/courseoverview?EID=108140 Description: This activity is intended for internal VUMC staff only and includes protected health information. This multidisciplinary tumor board brings together experts in treatment of gynecologic cancer (eg. Gynecologic Oncologists, Radiation Oncologists, Pathologists) to develop best treatment strategies for patients with gynecologic cancers based upon evidence-based guidelines, such as those produced by the Na... Online false MM/DD/YYYY


Wednesday, June 18, 2025, 7:00 AM - 8:00 AM, Online


Specialties - Other


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)


This activity is intended for internal VUMC staff only and includes protected health information. This multidisciplinary tumor board brings together experts in treatment of gynecologic cancer (eg. Gynecologic Oncologists, Radiation Oncologists, Pathologists) to develop best treatment strategies for patients with gynecologic cancers based upon evidence-based guidelines, such as those produced by the National Comprehensive Cancer Network (NCCN) and the American Society for Radiation Oncology (ASTRO).

Objective(s): 1 Utilize multidisciplinary approaches to the diagnosis and staging of patients with gynecologic cancer, including the findings from imaging, biopsy and surgery, genetic and molecular studies 2 Develop optimal treatment plans for the patients with cancer integrating surgery, radiation therapy, chemotherapy, targeted therapy and immunotherapy as needed 3 Describe evidence and/or guideline-based approaches to therapy as well as available clinical trials 4 Address the social determinants of health that affect the care of patients with gynecologic cancers
Location: Online
Specialties: Other

Faculty Disclosures:
Marta A Crispens, MD (Grant or research support-Sutro Pharaceuticals - 01/22/2025)



Objectives
After participating in this educational activity, you should be able to:

  1. Utilize multidisciplinary approaches to the diagnosis and staging of patients with gynecologic cancer, including the findings from imaging, biopsy and surgery, genetic and molecular studies
  2. Develop optimal treatment plans for the patients with cancer integrating surgery, radiation therapy, chemotherapy, targeted therapy and immunotherapy as needed
  3. Describe evidence and/or guideline-based approaches to therapy as well as available clinical trials
  4. Address the social determinants of health that affect the care of patients with gynecologic cancers


Vanderbilt University Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vanderbilt University Medical Center designates this live activity for a maximum 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.